In a sector of constant innovation, a company must be something special if even the experts are excited. These are the four ...

The Clinical Trials Arena team investigates the impact of government-led research funding cuts in clinical trials.

With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...

Analysts at StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Free Report) in a research report ...

UBS Group AG has hired three investment bankers specializing in biotechnology from RBC Capital Markets as the bank expands ...

The stock of 23andMe dropped 59% Monday after filing for federal bankruptcy protection and the exit of its CEO, a dramatic ...

Harmony Biosciences offers a promising investment with one commercial drug, WAKIX, and a robust pipeline, despite some ...

Philanthropies, especially from venture-minded or justice-driven donors, could step in where policy has stalled. By funding ...

Phil King’s investment firm was the largest shareholder in Opthea, the eye treatment play who warned it could be insolvent ...

For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

This was seen recently in January 2025, when GSK (LSE/NYSE: GSK) acquired IDRx, a Boston-based biotech specializing in precision therapies for gastrointestinal stromal tumors (GIST). Initially, GSK ...

(Reuters) -Danish drugmaker Novo Nordisk has secured the global rights to develop, manufacture and sell China-based United ...